[New attack point in anti-HIV therapy discovered. Docking of viruses to human cells can be prevented].
Baggiolini
M
M
Theodor-Kocher-Institut der Universität Bern.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000821:virology; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018946:Chemokine CCL5 / Q000031:analogs & derivatives / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors*
D019380:Anti-HIV Agents; D018946:Chemokine CCL5; D019707:Receptors, Chemokine